Oppenheimer Initiates Coverage On AppHarvest with Outperform Rating, Announces Price Target of $10
Oppenheimer analyst Kristen Owen initiates coverage on AppHarvest (NASDAQ:APPH) with a Outperform rating and announces Price Target of $10.
66 Biggest Movers From Yesterday
Gainers
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share.
Mid-Afternoon Market Update: Dow Surges Over 200 Points; HyreCar Shares Plunge
Toward the end of trading Wednesday, the Dow traded up 0.61% to 35,480.63 while the NASDAQ fell 0.30% to 14,743.90. The S&P also rose, gaining 0.18% to 4,444.91.
Mid-Day Market Update: Upstart Jumps Following Strong Q2 Results; ON24 Shares Slide
Midway through trading Wednesday, the Dow traded up 0.50% to 35,439.83 while the NASDAQ fell 0.45% to 14,722.22. The S&P also rose, gaining 0.09% to 4,440.95.
48 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) gained 82% to $25.19. The company, last month, priced its IPO at $11 per share.
AppHarvest Shares Plummet On Q2 Earnings Disappointment, Reduced FY21 Outlook
AppHarvest Inc (NASDAQ:APPH) reported second-quarter FY21 sales growth of 34.8% quarter-on-quarter, to $3.14 million, missing the analyst consensus of $5.87 million.…
Why AppHarvest Shares Are Getting Slammed Today
AppHarvest Inc (NASDAQ: APPH) is trading significantly lower Wednesday after the company announced worse-than-expected second-quarter financial results and cut guidance.